SLC5A2 and type 2 diabetes mellitus: For the comparison of efficacy between SGLT2-i plus metformin and metformin monotherapy as treatment in T2DM patients with inadequate glycemic control on metformin alone, we analyzed the changes from baseline of HbA1C, FPG and body weight, and all of the 9 articles were enrolled in the analysis.